26 September 2017 : Clinical Research
Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma
DOI: 10.12659/MSM.904154
Med Sci Monit 2017; 23:4619-4632
HTML version available soon